
Atazanavir
CAS No. 198904-31-3
Atazanavir( BMS-232632 )
Catalog No. M13109 CAS No. 198904-31-3
A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
![]() ![]() |
10MG | 57 | In Stock |
![]() ![]() |
25MG | 86 | In Stock |
![]() ![]() |
50MG | 113 | In Stock |
![]() ![]() |
100MG | 194 | In Stock |
![]() ![]() |
200MG | 291 | In Stock |
![]() ![]() |
500MG | 492 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAtazanavir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
-
DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture; shows synergistic antiviral effects in HIV-infected PBMCs; used to treat and prevent HIV/AIDS.HIV Infection Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-232632
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIVProtease
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number198904-31-3
-
Formula Weight704.8555
-
Molecular FormulaC38H52N6O7
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
-
Chemical Name2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
CX 04328
CX 04328 (LEDGIN-6) is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 1.37 uM.
-
PF-3450074
PF-3450074 (PF74) is a small molecule HIV capsid protein, destabilized the viral capsid in vitro; acts at an early stage of HIV-1 infection and inhibits reverse transcription in target cells.
-
HIV-1 Rev 34-50
HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. HIV-1 Rev peptide is a one of the cell-penetrating peptides (CPPs) derived from HIV-1 Rev protein residue 34-50. It is a RNA binding peptideand has been used to deliver macromolecules into cells.